CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation

The Centers for Medicare & Medicaid Services (CMS) has announced that drug manufacturers will participate in the third round of negotiations for Medicare drug prices. This change affects pharmaceutical companies that provide medications covered under Medicare. Agents should stay informed about these negotiations as they may impact drug pricing and availability for their clients.